CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

GlobeNewswire Clinical Studies
Original article

Opus Genetics Provides BEST1 Program Update with Detailed Timeline for OPGx-BEST1 Results

Data ReadoutOPGx-BEST1Neutral
AI Analysis

Summary

Opus Genetics announced an update to its BEST1 program and provided a detailed timeline for OPGx-BEST1 results. The article contains limited details about the specific outcome, timing, or clinical data.

Clinical Trial Data

Importance:4/10
Sentiment:
0.00
BEST1OPGx-BEST1program updateclinical trial

Read the original article

Published by GlobeNewswire Clinical Studies on July 9, 2026 11:00 AM

Read Original